Roche’s Lunsumio may be the first CD20xCD3 T-cell engager approved by the FDA, but intravenous administration puts the drug ...

CHICAGO -- Subcutaneous amivantamab (Rybrevant) was non-inferior to IV amivantamab for pre-treated patients with refractory EGFR-mutated, advanced non-small cell lung cancer (NSCLC), with the ...

A subcutaneous formulation of MSD's top-selling cancer immunotherapy, Keytruda, was non-inferior to the current intravenous version in a head-to-head trial, setting up regulatory filings.

Some hospital administrators say they are changing how they think about IV fluid hydration altogether. Hurricane Helene, which hit North Carolina in September, wrecked a Baxter International ...

The trial is evaluating the noninferiority of subcutaneous administration of pembrolizumab, Merck’s anti-PD-1 therapy, available for intravenous use as KEYTRUDA ®, together with ...

Some hospital administrators say they are changing how they think about IV fluid hydration altogether. Hurricane Helene, which hit North Carolina in September, flooded a Baxter International ...

Some hospital administrators say they are changing how they think about IV fluid hydration altogether. This story also ran on NPR. It can be republished for free. Hurricane Helene, which hit North ...